FDA approves Argus 2s Retinal Prosthesis System

The U.S. Food and Drug Administration has approved the Argus 2s Retinal Prosthesis System (Second Sight Medical Products), a redesigned set of external hardware (glasses and video processing unit) initially for use in combination with previously implanted Argus II systems for the treatment of retinitis pigmentosa (RP), according to a press release.

“We are very pleased to have received this approval, as it presents an opportunity to offer external hardware that we believe enhance comfort and aesthetics compared with the legacy Argus II system,” said Matthew Pfeffer, acting CEO of Second Sight, in a press release.